About Odevixibat (equivalent to odevixibat sesquihydrate 0.414 mg)
Class: | Bile acid transport inhibitor
Use: | Treatment of pruritus associated with cholestatic liver disease in pediatric patients aged 3 months and older
Adult dose: | Not established; primarily indicated for pediatric use
Pediatric dose: | 0.4 mg once daily for patients weighing less than 25 kg; 0.6 mg once daily for patients weighing 25 kg or more
Side effects: | Diarrhea, abdominal pain, nausea, vomiting, and liver enzyme elevations
Contraindications: | Hypersensitivity to odevixi
Drug Class
Bile acid transport inhibitor
Uses & Indications
Treatment of pruritus associated with cholestatic liver disease in pediatric patients aged 3 months and older
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture
Manufacturer & Packaging
Manufacturer: IPSEN PHARMA [ Boulogne- Billancourt;France], France
Package Size
30's HDPE Bottle
Price & Supplier
Price in UAE: AED 38517.00
Dosage Information
Adult Dose
Not established; primarily indicated for pediatric use
Pediatric Dose
0.4 mg once daily for patients weighing less than 25 kg; 0.6 mg once daily for patients weighing 25 kg or more
Side Effects
Diarrhea, abdominal pain, nausea, vomiting, and liver enzyme elevations
Contraindications & Precautions
Hypersensitivity to odevixibat or any component of the formulation; severe liver impairment
Important Warnings
Risk of liver injury; monitor liver function tests before and during treatment; not recommended for use in patients with severe hepatic impairment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.